Vicore Pharma (Sweden) Today
| VICO Stock | SEK 16.08 0.04 0.25% |
Performance6 of 100
| Odds Of DistressOver 60
|
Vicore Pharma is selling for under 16.08 as of the 19th of April 2024; that is -0.25 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 15.76. Vicore Pharma has more than 60 % chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Vicore Pharma Holding are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of April 2023 and ending today, the 19th of April 2024. Click here to learn more.
Vicore Pharma Holding AB , through its subsidiaries, operates as a biotech company. Vicore Pharma Holding AB was founded in 2000 and is based in Mlndal, Sweden. Vicore Pharma is traded on Stockholm Stock Exchange in Sweden. The company has 81.85 M outstanding shares. More on Vicore Pharma Holding
Moving against Vicore Stock
| 0.71 | GENO | Genovis AB | PairCorr |
| 0.63 | ARION-SDB | Arion banki hf | PairCorr |
| 0.63 | HEIM-PREF | Heimstaden AB Pfd | PairCorr |
| 0.54 | HNSA | Hansa Biopharma AB | PairCorr |
| 0.42 | BIOA-B | BioArctic AB | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Vicore Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Vicore Pharma's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Vicore Pharma or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Vicore Pharma Holding (VICO) is traded on Stockholm Exchange in Sweden and employs 23 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.26 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Vicore Pharma's market, we take the total number of its shares issued and multiply it by Vicore Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Vicore Pharma Holding operates under Healthcare sector and is part of Biotechnology industry. The entity has 81.85 M outstanding shares.
Vicore Pharma Holding has accumulated about 215.97 M in cash with (265.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.1.
Check Vicore Pharma Probability Of Bankruptcy
Ownership AllocationVicore Pharma maintains a total of 81.85 Million outstanding shares. Over half of Vicore Pharma's outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Vicore Pharma Holding. Please watch out for any change in the institutional holdings of Vicore Pharma as this could mean something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Vicore Ownership Details
Vicore Stock Price Odds Analysis
Attributed to a normal probability distribution, the odds of Vicore Pharma jumping above the current price in 90 days from now is about 19.93%. The Vicore Pharma Holding probability density function shows the probability of Vicore Pharma stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Vicore Pharma has a beta of 0.0745. This entails as returns on the market go up, Vicore Pharma average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Vicore Pharma Holding will be expected to be much smaller as well. Additionally, vicore Pharma Holding has an alpha of 0.2827, implying that it can generate a 0.28 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Vicore Pharma to move above the current price in 90 days from now is about 19.93 (This Vicore Pharma Holding probability density function shows the probability of Vicore Stock to fall within a particular range of prices over 90 days) .
Vicore Pharma Holding Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Vicore Pharma market risk premium is the additional return an investor will receive from holding Vicore Pharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Vicore Pharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Vicore Pharma's alpha and beta are two of the key measurements used to evaluate Vicore Pharma's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.44 | |||
| Semi Deviation | 2.01 | |||
| Standard Deviation | 3.73 | |||
| Variance | 13.95 |
Vicore Stock Against Markets
Picking the right benchmark for Vicore Pharma stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Vicore Pharma stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Vicore Pharma is critical whether you are bullish or bearish towards Vicore Pharma Holding at a given time. Please also check how Vicore Pharma's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Vicore Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Content Syndication Now
Content SyndicationQuickly integrate customizable finance content to your own investment portal |
| All Next | Launch Module |
Vicore Pharma Corporate Management
Elected by the shareholders, the Vicore Pharma's board of directors comprises two types of representatives: Vicore Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Vicore. The board's role is to monitor Vicore Pharma's management team and ensure that shareholders' interests are well served. Vicore Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Vicore Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kicki Johansson | Chief Officer | Profile | |
| Johan Raud | Chief Officer | Profile | |
| Elin Rosendahl | VP Devel | Profile | |
| Nina Carlen | Chief Officer | Profile | |
| Asa Magnusson | Chief Officer | Profile | |
| Rohit Batta | Chief Officer | Profile | |
| Hans Jeppsson | Chief Officer | Profile |
How to buy Vicore Stock?
Before investing in Vicore Pharma, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Vicore Pharma. To buy Vicore Pharma stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Vicore Pharma. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Vicore Pharma stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Vicore Pharma Holding stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Vicore Pharma Holding stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Vicore Pharma Holding, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Vicore Pharma Holding?
The danger of trading Vicore Pharma Holding is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Vicore Pharma is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Vicore Pharma. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Vicore Pharma Holding is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vicore Pharma Holding. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Complementary Tools for Vicore Stock analysis
When running Vicore Pharma's price analysis, check to measure Vicore Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vicore Pharma is operating at the current time. Most of Vicore Pharma's value examination focuses on studying past and present price action to predict the probability of Vicore Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vicore Pharma's price. Additionally, you may evaluate how the addition of Vicore Pharma to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |